Antibody Response to Coronavirus Disease 2019 (COVID-19) Messenger RNA Vaccination in Pregnant Women and Transplacental Passage Into Cord Blood.
Where this comes from
- Record sourced from PubMed, PMID 33910219.
- Also identified by DOI 10.1097/AOG.0000000000004438 and PMC identifier 8288193.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coronavirus disease 2019 (COVID-19) vaccination in pregnancy induces a robust maternal immune response, with transplacental antibody transfer detectable in cord blood as early as 16 days after the first dose.
Medical subject headings
- COVID-19
- Pregnancy Complications, Infectious